Gallstone disease cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| Line 13: | Line 13: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
| Line 18: | Line 20: | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 21:48, 29 July 2020
|
Gallstone disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
Gallstone disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Gallstone disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Gallstone disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]
Overview
Laparoscopic cholecystectomy is considered the most cost effective treatment since it prevents recurrence and complications from happening in the future.
Cost-effectiveness of Therapy
- Economical therapies include laparoscopic cholecystectomy.[1][2]
- It is considered cost-effective since laparoscopic cholecystectomy removes gallstones 99% of the time and avoids the need for prolonged hospital stays, recovery time, medical costs and future intervention.
References
- ↑ Darzi A, Geraghty JG, Williams NN, Sheehan SS, Tanner AN, Keane FB (1994). "The pros and cons of laparoscopic cholecystectomy and extracorporeal shock wave lithotripsy in the management of gallstone disease". Ann R Coll Surg Engl. 76 (1): 42–6. PMC 2502162. PMID 8054014.
- ↑ Portincasa P, van de Meeberg P, van Erpecum KJ, Palasciano G, VanBerge-Henegouwen GP (1997). "An update on the pathogenesis and treatment of cholesterol gallstones". Scand. J. Gastroenterol. Suppl. 223: 60–9. PMID 9200309.